XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Schedule of Financial assets and financial liabilities measured at fair value on a recurring basis (Parenthetical) (Detail) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Short-term contingent consideration $ 27,834 [1] $ 13,950
Avitide, Inc.    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Short-term contingent consideration due $ 14,500  
[1] The $27.8 million of short-term contingent consideration includes $14.5 million due and payable to the remaining securityholders of Avitide related to the First Earnout Year as defined in the Agreement and Plan of Merger and Reorganization with Avalon Merger Sub, Inc., which the Company entered into as part of the acquisition of Avitide in 2021. This amount is anticipated to be paid in the second quarter of 2023.